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A Randomized Controlled Trial: Attachment-Based
Family and Nondirective Supportive Treatments
for Youth Who Are Suicidal
Guy S. Diamond, PhD, R. Roger Kobak, PhD, E. Stephanie Krauthamer Ewing, PhD, MPH,
Suzanne A. Levy, PhD, Joanna L. Herres, PhD, Jody M. Russon, PhD, Robert J. Gallop, PhD
Objective: To evaluate the efficacy of attachment-based family therapy (ABFT) compared with a family-enhanced nondirective supportive therapy
(FE-NST) for decreasing adolescents’ suicide ideation and depressive symptoms.
Method: A randomized controlled trial of 129 adolescents who are suicidal ages 12- to 18-years-old (49% were African American) were randomized to
ABFT (n ¼ 66) or FE-NST (n ¼ 63) for 16 weeks of treatment. Assessments occurred at baseline and 4, 8, 12, and 16 weeks. Trajectory of change and
clinical recovery were calculated for suicidal ideation and depressive symptoms.
Results: There was no significant between-group difference in the rate of change in self-reported ideation (Suicidal Ideation Questionnaire-Jr; F1,127 ¼
181, p ¼ .18). Similar results were found for depressive symptoms. However, adolescents receiving ABFT showed a significant decrease in suicide
ideation (t127 ¼ 12.61, p < .0001; effect size, d ¼ 2.24). Adolescents receiving FE-NST showed a similar significant decrease (t127 ¼ 10.88, p < .0001;
effect size, d ¼ 1.93). Response rates (ie, 50% decrease in suicide ideation symptoms from baseline) at post-treatment were 69.1% for ABFT versus
62.3% for FE-NST.
Conclusion: Contrary to expectations, ABFT did not perform better than FE-NST. The 2 treatments produced substantial decreases in suicidal
ideation and depressive symptoms that were comparable to or better than those reported in other more intensive, multicomponent treatments. The
equivalent outcomes could be attributed to common treatment elements, different active mechanisms, or regression to the mean. Future studies will
explore long-term follow up, secondary outcomes, and potential moderators and mediators.
Clinical trial registration information: Attachment-Based Family Therapy for Suicidal Adolescents; http://clinicaltrials.gov; NCT01537419.
Key words: suicide, depression, attachment, treatment
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uicide is the third leading cause of death in
American adolescents, accounting for 4,600
deaths each year. In addition, nearly 1 million
adolescents attempt suicide each year, resulting in roughly
500,000 emergency room admissions.1 Adolescent suicide
results in high emotional costs for families and financial
costs for the health care system. Using broad selection
criteria, a recent review found 18 randomized control trials
(RCTs) that examined psychosocial (with or without
medication) treatments for adolescents with suicide ideation
or behaviors.2 Only 6 of these treatments met criteria for
being probably or possibly efficacious. Furthermore, nearly
all these treatments were supported by randomized trials
that compared the treatment of interest with treatment as
usual (TAU) in the community. These TAU comparison
groups are highly variable in the number of sessions and
nature of treatment received. As a result, interpretations of
findings from studies using TAU as a comparison group are
tenuous.3 Surprisingly, there have been few RCTs for
adolescents who are suicidal that have compared 2 manual-
based, supervised, monitored treatments provided within
the same research center. The present study tested the hy-
pothesis that attachment-based family therapy (ABFT)4
would perform better than a manual-based commonly
used nondirective individual supportive therapy5 enhanced
with a parent education program.
ABFT has been designated as a probably efficacious
treatment for suicidal thoughts and behaviors and for
depression and depressive symptoms2 and is listed on the
National Registry of Evidence-based Program and Practices
for suicidal thoughts and behaviors and depression. ABFT
provides a manual-based series of sequenced tasks, occurring
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in individual and family sessions, that aim to identify and
resolve attachment ruptures that have compromised adoles-
cents’ trust in their parents (eg, divorce, parental psychopa-
thology, critical parenting). Working through these ruptures
can increase the adolescent’s confidence in a parents’ avail-
ability6 and increase the adolescent’s capacity for problem
solving and ability to use the parent as a resource for regu-
lating affect and managing suicidal thoughts and feelings.
When adolescents view parents as sensitive, safe, and avail-
able, they are more likely to turn to parents for support that
can buffer against common triggers for depressive feelings
and suicide ideation (eg, grief and loss, bullying, school
failure, romantic relationships, and family conflict).7 Studies
have demonstrated that ABFT is more effective for this
population than waitlist control or TAU.8 ABFT also has
been successfully disseminated to community settings.9,10
Clinical Vignette
Sophia is a 16-year-old white girl currently in the 10th grade.
Sophia has never met her father. When Lisa, Sophia’s mother,
lost her job, they moved in with the maternal grandmother.
Sophia was 10 years old. Lisa become depressed and
through a new boyfriend became addicted to oxycodone.
When Sophia was 13, Lisa moved in with her boyfriend and
left Sophia with her grandmother. Lisa visited sporadically
but eventually got arrested and went to a rehab program for
9 months. Six months after discharge, Lisa was stable and
moved back into the home with the grandmother and
Sophia. During Lisa’s absence, Sophia began to act out,
experimenting with drugs and risky sexual behavior. When a
friend’s mother discovered this, it led to a referral to a ther-
apy program. At Sophia’s intake, it became clear that her
drug use and sexual behaviors were her best attempt at
coping with her depression and suicidal impulses. Wanting to
resume parenting of her daughter, Lisa brought Sophia to the
first session, which infuriated Sophia. After some history
gathering and assessment of the depression, the therapist
focused on the motheredaughter relationship. “So Sophia,
when you feel so bad, like you want to kill yourself, why don’t
you turn to your mother for help?” Sophia was reluctant to
talk. Lisa resentfully said that Sophia thought she was all
grown up and independent. Sophia said, “She does her thing
and I do mine. I don’t need her anymore.” Because it was the
first session, the therapist did not explore this in depth but
empathically remarked that the distance between them was
apparent and tragic. Commenting how disjointing this must
feel, Lisa began to cry and Sophia looked on scornfully. The
therapist said that maybe if they could work through some of
these past hurts, they could be close again or at least not
carry around such guilt (mother) and resentment (daughter).
The family agreed to consider this attachment-focused
treatment plan.
In a session alone with Sophia, the therapist explored
her depression, suicidal feelings, and risky sexual behavior.
The goal was not to change it (yet) but to help Sophia
acknowledge for herself how miserable she felt and to make
this her problem rather than everyone else’s. In another
session, the discussion focused on her mother. With a gentle
directive approach, Sophia began to broaden her attach-
ment narrative. Rather than just feel rage at her “selfish
mother,” Sophia allowed herself to feel the shame and
disappointment of abandonment. She began to understand
how feeling worthless and rejected by her mother allowed
her to let boys to take advantage of her. When the timing
was right in the third session alone, the therapist proposed
that expressing her anger directly to her mother might help
rid her of these ghosts of self-hatred. Sophia reluctantly
agreed, and during the next session the therapist helped
prepare Sophia for this conversation. Simultaneously, the
therapist was having individual sessions with Lisa. Several
sessions explored her current stressors related to getting her
life back on track. One session focused on her relationship
with her parents. The loss of her father when she was 11
devastated her, and her own mother’s grief and withdrawal
felt rejecting. Helping Lisa remember and feel her own
experience of abandonment gave the therapist the oppor-
tunity to help her more empathically understand how Sophia
might have felt when she left. Lisa, preoccupied with her own
recovery, never really stopped to consider the impact her
drug abuse had on her daughter. This moment of empathic
sensitivity, of reflective functioning, motivated Lisa to let the
therapist teach her some different, more emotion-focused,
parenting skills.
At approximately week 8, the therapist brought the
mother and daughter back together. Sophia expressed more
directly, and in a more regulated manner, her hurt and feel-
ings of abandonment. Lisa, rather than being defensive,
empathically listened and encouraged Sophia to share these
feelings and memories with her. When the timing was right,
Lisa apologized for her actions. Sophia listened but did not
feel moved to forgive her. Lisa had to accept that. However,
when leaving the session, Sophia did allow her mother to put
her arm around her shoulder. Two more sessions focused on
helping the family discuss these past traumas and injustice.
The grandmother participated in 1 of these sessions. As the
tension at home dissipated, Sophia’s depression lessened.
Problems persisted with weekend drinking and Lisa had to
increase her monitoring and setting of limits. Sophia resented
this at first. The therapist helped frame this as her mother not
wanting to abandon Sophia again by ignoring these prob-
lems. Sophia became more receptive when limits were
viewed as protection rather than punishment. At the end of
the short-term treatment (16 weeks), Sophia’s depression and
suicide ideation were out of clinical range. Then, the thera-
pist referred Sophia to a dialectical behavior therapist to help
her develop more effective emotion regulation sills.
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Nondirective supportive therapy (NST) has been used
as an active control condition in treatments of adolescent
and adult depression. In NST, the central goal is to
augment the adolescent’s access to supportive adult re-
lationships through the adolescent’s relationship with the
therapist. Therapists implement NST by focusing on
reflective listening, empathizing with the adolescent’s ex-
periences of stress, and supporting the adolescent in artic-
ulating and exploring thoughts and feelings. In a study of
adolescents with major depressive disorder, cognitive-
behavioral therapy (CBT) proved more effective than sys-
temic behavior family therapy or NST in decreasing
depressive symptoms.5,11 However, Brent et al.5 reported
equivalent decreases in suicidal symptoms and functional
impairment in the NST, CBT, and systemic behavior
family therapy conditions. In another study, NST produced
equivalent decreases in suicide ideation and depressed mood
compared with a directive skills-based protocol.11 The
effectiveness of NST also extends to treatments of adult
depression. In a meta-analysis of 31 studies on treatments
for adult depression, NST was as effective as other active
treatments,12 particularly when controlling for investigator
allegiances. In this way, NST provides a rigorous test of the
active ingredients of ABFT by controlling for a supportive
therapeutic relationship and reflective listening as nonspe-
cific factors of therapy.
To test the superiority of ABFT against NST, we
randomized adolescents who are suicidal and their families
to the 2 treatment conditions. Many characteristics of this
RCT were designed to control for common treatment
elements in ABFT and NST. First, a 5-session parent
psychoeducation program was added to the NST condi-
tion to control for parent involvement in ABFT. Thus, we
refer to the treatment used in this RCT as family-enhanced
NST (FE-NST). Second, all patients received safety
planning. Third, therapists implemented ABFT and
FE-NST to control for therapist effects. Fourth, with the
exception of 4 cases, treatment was implemented by
trained community therapists. Fifth, treatment dosage was
controlled by delivering the 2 treatments for 16 weeks
with occasional 2 weekly sessions to incorporate parent
sessions. Sixth, severe and persistent suicidal ideation and
moderate depression were used as inclusion criteria. These
criteria establish a common clinical presentation and
increased risk for suicide attempts.13,14 Seventh, this study
incorporated a diverse racial and ethnic sample, providing
a test of the generalizability of treatment effects across race
and social class. Suicide rates for minority youth have
increased,15 yet minorities remain under-represented in
clinical trials.16
METHOD
Participants
Participants were recruited from emergency departments
(37.9%), inpatient psychiatric hospitals (6.9%), mental
health agencies or primary care sites (20.9%), schools
(10.8%), and community clinicians or self-referrals (23.5%;
Figure 1). Eligibility for the study included at least clinically
significant levels of suicidal ideation (Suicidal Ideation
Questionnaire-Junior [SIQ-JR] score  3117) and moderate
levels of depressive symptoms (Beck Depression Inventory
II [BDI-II] score > 2017). Participants were screened using
a multigate procedure over 2 pre-randomization time
points. Participants were screened using the BDI-II and
SIQ-JR, first over the phone and then at a face-to-face clinic
visit, usually within 72 hours of the initial screening. To be
eligible, participants were required to meet inclusion criteria
at the 2 pretreatment screens. At least 1 primary caregiver
was required to participate in assessments and treatments.
Exclusion criteria included imminent risk of harm to
self or others that could not be safely treated on an
outpatient basis; psychotic features; severe cognitive
impairment based on educational records, parent report,
and/or clinical impression; and non–English-speaking
participating parent. Participants who began psychiatric
medication within 3 weeks of the initial pretreatment
screening also were ineligible to participate. The protocol
was approved by the institutional review boards at the
Children’s Hospital of Philadelphia, Drexel University, and
the City of Philadelphia. The study was monitored quarterly
by a data safety and monitoring board. Participants were
enrolled from May 1, 2012 through December 31, 2015
and provided written informed consent or assent (<14 years
of age).
Participants included 129 adolescents (81.9% girls) 12
to 18 years old (mean 14.87, SD 1.68). Sixty-four ado-
lescents identified as African American (49.7%), 37 as
white (28.7%), 3 as Asian (2.3%), 2 as American Indian or
Alaskan Native (1.6%), and 1 as Native Hawaiian or Pacific
Islander (0.8%). Ten adolescents identified as biracial or
multiracial (7.8%) and 12 identified as “other” (9.3%).
Most of the sample identified as non-Hispanic/Latino
(84.5%) and 31% of adolescents identified as gay,
lesbian, or bisexual. Parents reported that 69% were single-
headed households and 31% had incomes below the
poverty line (Table 1). At baseline, the average score for
suicidal ideation on the SIQ-JR was 49.89 (SD 15.2), and
the average score on the BDI was 30.5 (SD 7.97; Table 2).
Forty-two percent of participants had made at least 1 sui-
cide attempt in their lifetime, 25% had a history of psy-
chiatric hospitalization, and 57.5% reported a history of
Journal of the American Academy of Child & Adolescent Psychiatry www.jaacap.org 723
Volume 58 / Number 7 / July 2019
ABFT VERSUS NST
nonsuicidal self-injury as indicated by the Columbia-
Suicide Severity Rating Scale (C-SSRS).18 At intake,
41.2% met criteria for major depressive disorder, 3.9% met
criteria for dysthymia, and 46.93% met criteria for an
anxiety disorder on the Diagnostic Interview Schedule for
Children–IV (DISC-IV).18 At the time of intake, 27.1% of
participants were currently taking medication for depression
and 9.3% were taking medication for other behavioral or
emotional problems.
Procedures
After the baseline assessment, urn randomization assigned
participants to 16 weeks of ABFT or NST. Stratification
variables included gender, history of attempt, and
endorsement of high levels of family conflict (score > 13 on
the Conflict subscale of the Self-Report of Family Func-
tioning [SRFF]19). Outcomes assessments were adminis-
tered at weeks 0 (baseline), 4, 8, 12, and 16 (post-treatment
assessment). Follow-up assessments were completed at
FIGURE 1 CONSORT Table
Note: ABFT ¼ attachment-based family therapy; FE-NST ¼ family-enhanced nondirective supportive therapy.
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TABLE 1 Frequencies for Sample Demographic Characteristics (N ¼ 129)
Variable
Total (N ¼ 129) ABFT (n ¼ 66) NST (n ¼ 63)
c2Frequency % Frequency % Frequency %
Race 3.09
American Indian/Alaskan Native 2 1.6 0 0.0 2 3.2
Asian 3 2.3 2 3.0 1 1.6
White 37 28.7 21 31.8 16 25.4
African American 64 49.6 31 47.0 33 52.4
Native Hawaiian/Pacific Islander 1 0.8 0 0.0 1 1.6
Biracial/multiracial 10 7.8 6 9.1 4 6.3
Other 12 9.3 6 9.1 6 9.5
Hispanic 20 15.5 11 16.7 9 14.3 0.14
Relationship status 0.53
Single 89 69.0 45 68.2 44 69.8
In relationship 36 27.9 19 28.8 17 27.0
Physical abuse 23 17.8 9 13.6 14 22.2 1.74
Sexual abuse 25 19.4 13 19.7 12 19.0 0.01
Religion 8.41
Catholic 28 21.7 13 19.7 15 23.8
Other Christian 45 34.9 24 36.4 21 33.3
Jewish 3 2.3 1 1.5 2 3.2
Muslim 5 3.9 5 7.6 0 0.0
Buddhist 2 1.6 1 1.5 1 1.6
Hindu 1 0.8 1 1.5 0 0.0
Atheist 15 11.6 9 13.6 6 9.5
Other 30 23.3 12 18.2 18 28.6
Gender 0.01
Female 95 81.9 55 83.3 52 82.5
Male 22 18.1 11 16.7 11 17.5
Age 0.16
Age 15 y 76 58.9 36 57.1 40 60.6
Sexual orientation 8.68*
Heterosexual 88 68.2 38 57.6 50 79.4 7.06**
Lesbian/gay 10 7.8 8 12.1 2 3.2 3.61
Bisexual 22 17.1 13 19.7 9 14.3 0.67
Questioning 9 7.0 7 10.6 2 3.2 2.74
Per capita ratio
Below poverty line 40 31.3 21 32.3 19 30.2 0.69
Prior suicide attempt (yes/no) 51 39.5 29 43.9 22 34.9 1.10
History of NSSI (yes/no) (n [ 126) 73 57.9 31 48.4 42 67.6 4.82*
Any mood disorder (n [ 113) 50 44.2 27 48.2 23 40.4 0.71
Any anxiety disorder (n [ 113) 53 46.9 27 48.2 26 45.6 0.77
Any substance disorder (n [ 112) 11 9.8 7 12.5 4 7.1 0.91
Oppositional defiant disorder
(n [ 113)
11 9.8 3 5.4 8 14.0 2.42
Note: ABFT ¼ attachment-based family therapy; NSSI ¼ nonsuicidal self-injury; NST ¼ nondirective supportive therapy.
*p < .05; **p < .01.
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weeks 24, 32, 40, and 52 but are not included in this
report. Assessment staff was blinded to treatment condition.
Therapist and Therapist Training. Over a period of 4 years,
14 therapists delivered the treatments. Eleven therapists
were women. Five therapists had a master’s degree and 9
had doctoral degrees. To control for potential therapist ef-
fects, the same therapists delivered the 2 treatments.
Therapists received training in the 2 treatments by reading
the manuals, attending a 2- to 3-day training workshop, and
treating pilot cases or conducting cotherapy with experi-
enced project therapists. Then, therapists received weekly
supervision from expert ABFT and NST supervisors. The 2
doctoral-level ABFT supervisors had a primary allegiance to
ABFT. Of the 3 doctoral-level NST supervisors, 2 had a
primary allegiance to CBT and 1 had an allegiance to
couples and family therapy.
Adherence Ratings. To evaluate treatment fidelity and
differentiation, raters used an adherence measure that
included 22 items (17 items for tasks in ABFT and 7 items
that were specific to FE-NST). Raters used a 7-point Likert
scale ranging from 0 (not present) to 6 (very thorough and
consistent) to rate all items for all tapes regardless of con-
dition. After training, 5 raters blinded to treatment condi-
tion scored a total of 290 sessions, representing 20% of total
sessions from 118 cases. Intraclass correlation coefficients
showed a mean coder reliability with an a value equal to
0.88. Data showed that ABFT and NST were delivered
with high fidelity (eg, treatment as intended), with 91% of
tapes coded showing adherence scores higher than 4 for
ABFT scales (mean 4.67, SD 6.04) and adherence scores
higher than 4 for NST scales (mean 4.22, SD 4.40). For
differentiation, the 7 nonspecific treatment items from NST
interventions were somewhat present in ABFT as expected,
but fewer than 10% of ABFT items were rated higher than
0 in the NST condition.
Treatments. Informed by attachment theory, ABFT4 pur-
ports that depressive symptoms and suicidality can be
precipitated, exacerbated, or buffered against by the quality
of family relationships. Family problems such as high con-
flict, parental abdication or over-control, or more insidious
traumas such as abandonment, neglect, or abuse, can
rupture adolescents’ confidence in parents’ availability with
accompanying feelings of anger and anxiety. As a result,
these youth are less likely to turn to parents for help with
life’s challenges. In individual sessions with the adolescent,
the therapist helps the teen to understand how these rup-
tures fuel distress, contribute to self-destructive behavior,
and compromise the adolescent’s ability to use parents as a
resource for managing suicidal thoughts and feelings. The
therapist prepares the adolescent to discuss these ruptures
with the parent. The therapist also works with the parent
alone to better understand how current stressors and
attachment history might inhibit the parent from providing
more emotionally supportive parenting. Then, in conjoint
sessions, adolescents begin to express their perceived in-
justices and emotional disappointment, and parents are
coached to acknowledge and validate the adolescents’ feel-
ings. This phase is designed to enact a corrective attachment
experience. As trust and open communication improve,
treatment shifts to promoting the adolescent’s autonomy in
domains outside the family. Although ABFT is focused on
process and trauma, the manual offers structure and pro-
cedures to accomplish these treatment goals within a 16-
week treatment protocol.
FE-NST is a modification of the individual, supportive
relationship treatment manual.20 Over 16 sessions, this
therapy focuses on developing a supportive relationship
between the adolescent and the therapist. Specifically, the
therapist engages with the adolescent by listening, empa-
thizing, identifying feelings, attending to affect, offering
support and validation, and providing summarizing state-
ments that might bring more meaning to the adolescent’s
experiences. These treatment factors, common to many
psychotherapies,21 are believed to counteract the patient’s
feeling of thwarted belongingness, helplessness, and hope-
lessness by establishing a close relationship with the thera-
pist. For this RCT, sessions with the adolescent were
TABLE 2 Mean and Standard Deviation for Baseline Measure (N ¼ 129)
Variable
Total (N ¼ 129) ABFT (n ¼ 66) NST (n ¼ 63)
tMean SD Mean SD Mean SD
SIQ Monthly 49.89 15.16 49.49 14.66 50.27 15.73 L0.29
BDI (adolescent) 30.54 7.97 31.06 7.68 29.99 8.29 L0.76
Conflict 10.89 3.37 10.89 3.24 10.89 3.53 0.01
Cohesion 14.37 3.37 14.30 3.34 14.44 3.43 0.23
Note: ABFT ¼ attachment-based family therapy; BDI ¼ Beck Depression Inventory II; NST ¼ nondirective supportive therapy; SIQ ¼ Suicidal Ideation
Questionnaire.
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augmented with 1 conjoint parent–adolescent session to do
safety planning and 4 parent education sessions without the
adolescent. Parent education sessions focused on suicide risk
assessment, understanding depression, advocacy and
resource development, and problem solving.
Primary Outcome Measures
Suicidal Ideation. The SIQ-JR Monthly22 is a 15-item
measure assessing thoughts of suicide over the past
month. Adolescents rate the frequency of suicidal thoughts
on a 7-point scale. Sum scores can range from 0 to 90, with
scores higher than 31 indicating clinical levels of ideation.
Previous studies have shown that the SIQ-JR has high in-
ternal consistency (a ¼ 0.93–0.96).19 Internal consistency
in this sample yielded an a value equal to 0.86.
Depressive Symptoms. The BDI-II17 has 21 self-reported
items assessing severity of depressive symptoms. Responses
for each item are scored on a scale of 0 to 3, with the sum of
all items ranging from 0 to 63. Previous studies have shown
that the BDI-II has high internal consistency (a ¼ 0.91)
and is positively correlated with other measures of depres-
sion. In this sample, the scale demonstrated internal con-
sistency, yielding an a value equal to 0.85.
Suicide Severity. The C-SSRS23 is an interview-based
measure designed to create a topology of suicidal behavior
and ideation. For this study, the C-SSRS was used to
identify whether the adolescent had a lifetime suicide
attempt history and/or a history of nonsuicidal self-injury.
Family Conflict and Cohesion. The SRFF19 consists of 15
items measuring cohesion, conflict, and democratic family
style. Previous studies have shown Cronbach a values ranging
from 0.63 to 0.91, with most in the 0.70 to 0.85 range. In this
sample, internal consistency for the Conflict and Cohesion
scales yielded a values of 0.70 and 0.88, respectively.
Psychiatric Diagnoses. The DISC is a structured psychiatric
diagnostic interview that evaluated more than 30 psychiatric
diagnoses based on DSM-IV criteria. For the present study,
the DISC modules for various anxiety disorders, mood dis-
orders, oppositional defiant disorder, and substance abuse
were administered to participating adolescents.
Data Analysis
Tests of baseline differences in demographic and clinical
characteristics were conducted using independent-samples t
tests for continuous variables and c2 or Fisher exact tests for
categorical variables. Before analysis, inspection of the 2
continuous outcomemeasures, SIQ-JR and BDI-II, identified
significant deviations from normality. Box-Cox trans-
formations indicated that a square root transformation
corrected the positive skew for the SIQ-JR and the BDI-II.
Suicide attempts and nonsuicidal self-injury (measured
through the C-SSRS) were treated as binary (history versus no
history).
Hierarchical linear modeling tested treatment differ-
ences in rates of change across the full 16 weeks of treat-
ment using the intent-to-treat sample.24 For the SIQ-JR
and the BDI, the main efficacy analysis modeled the rate
of log-linear change from baseline to 16 weeks (end of active
treatment).25 All patients were included in the hierarchical
linear model corresponding to a full intent-to-treat analysis.
Hierarchical generalized linear modeling was used to
accommodate the binary outcome (ie, suicide attempts),
while accounting for clustering of repeated measures within
each subject.26 Effect size was measured using the Cohen
d for continuous outcomes and odds ratios for the binary
outcome.27 The odds ratio corresponded to, on average, the
number of times an event was more likely to occur for
ABFT compared with FE-NST at each assessment.
Nonparametric Wilcoxon rank sum tests assessed the
number of sessions attended. The c2 analyses assessed
treatment retention.28 The pattern-mixture model approach
assessed whether missing data had a substantive influence
on results. The methodology of Jacobson et al.29 was used
to assess reliable change. Clinical significance was based on
established thresholds for each measure. All analyses were
conducted using SAS 9.4 (SAS Institute, Cary, NC).
Statistical Power
Using the method described by Diggle et al.30 and Ahn
et al.,31 power formulas for linear mixed models with
repeated measures showed that the analysis of the SIQ-JR
was well powered with a targeted sample size of 110 pa-
tients (55 completers per group). A priori, using an a level
at 0.05 based on a 2-tailed test and assuming a within
correlation of 0.5 with 4 post-baseline assessments, we had
power of 91.2% and 80.0% to detect a between-
intervention effect size of 0.50 and 0.42, respectively. In
addition, the study had greater than 80% power to detect a
difference in the proportion of suicide attempts (yes versus
no) of at least one-sixth.
RESULTS
Treatment Retention
There was no significant difference between the number of
sessions attended by ABFT participants (mean 14.34, SD
7.58) and FE-NST participants (mean 12.67, SD 5.74;
t127 ¼ 1.43, p ¼ .16). There was no significant difference
between the number of weeks attended by patients in the 2
treatments (ABFT, mean 9.68, SD 4.72; FE-NST, mean
9.43, SD 4.20; t127 ¼ 0.32, p ¼ .75). Dropout rates were
Journal of the American Academy of Child & Adolescent Psychiatry www.jaacap.org 727
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not significantly different between treatment groups, with
18.2% attrition for ABFT compared with 17.5% for FE-
NST (c2[1, N ¼ 129] ¼ 0.02, p ¼ .92; Figure 1).
Suicide Ideation
There was no significant between-group difference in the
rate of change in self-reported ideation (SIQ-JR; F1,127 ¼
1.81, p ¼ .18; Figure 2). The estimated total change from
baseline to end of treatment (week 16) was 31.55 (SE
2.50) for ABFT and 27.42 (SE 2.52) for FE-NST. On
average, ABFT participants showed a significant decrease in
suicidal ideation (t127 ¼ 12.61, p < .0001; effect size, d ¼
2.24). Similarly, participants in the FE-NST showed a
significant decrease in suicidal ideation (t127 ¼ 10.88, p <
.0001; effect size, d ¼ 1.93).
Remission (below clinical cutoff) rates in suicide ideation
(ie, SIQ-JR score< 12) were 14.3% for ABFT versus 12.1%
for FE-NST at 4 weeks, 25.0% for ABFT versus 11.5% for
FE-NST at 8 weeks, 24.5% for ABFT versus 26.5% for FE-
NST at 12 weeks, and 32.7% for ABFT versus 24.5% for
FE-NST at post-treatment (16 weeks). There were no sig-
nificant between-treatment differences in remission rates
over the 16 weeks of treatment.
Response rates (ie, 50% decrease in SIQ-JR score from
baseline) were 32.1% for ABFT versus 32.8% for FE-NST at
4 weeks, 51.9% for ABFT versus 36.5% for FE-NST at
8 weeks, 58.5% for ABFT versus 51.0% for FE-NST at 12
weeks, and 69.1% for ABFT versus 62.3% for FE-NST at
post-treatment (16 weeks). The differences in treatment
response rates between the 2 conditions were not significant.
Reliable change in SIQ-JR score required difference scores of
at least 23.02. The reliable change was 56.6% for
ABFT versus 49.2% for FE-NST at post-treatment (week 16),
with no significant differences between the 2 conditions.
Depressive Symptoms
There was no difference between the 2 treatment conditions
in the rate of change in depression (BDI-II) over the course
of treatment (F1,127 ¼ 0.11, p ¼ .74; Figure 3). The esti-
mated total change from baseline to end of treatment
was 5.40 (SE 0.50) for ABFT and 4.87 (SE 0.50) for
FE-NST on the BDI-II. Participants in the ABFT group
showed a significant decrease in BDI-II score (t127 ¼ 10.72,
p < .0001; effect size, d ¼ 1.90). Similarly, FE-NST par-
ticipants showed a significant decrease in BDI-II score
(t127 ¼ 9.68, p < .0001; effect size, d ¼ 1.72).
Remission rates in depressive symptoms (ie, BDI-II
score < 9)32 were 7.1% for ABFT versus 15.5% for FE-
NST at week 4, 19.2% for ABFT versus 11.8% for FE-
NST at week 8, 35.9% for ABFT versus 18.4% for
FE-NST at week 12, and 40.0% for ABFT versus 34.0%
for FE-NST at post-treatment (week 16). A significant
between-treatment difference in response rates per depres-
sive symptoms was seen at 12 weeks favoring ABFT over
FE-NST (odds ratio 2.88, 95% CI 1.10-7.60; c21 ¼ 4.60,
p ¼ .03). Reliable change in BDI-II score required differ-
ence scores of at least 12.10. These rates were 70.9% for
ABFT versus 56.6% for FE-NST at post-treatment (week 16).
There were no significantly different reliable change scores
between treatment conditions across the treatment course.
Suicide Attempts
During the course of treatment, 6 of the 129 adolescents
reported making a suicide attempt during the treatment
phase. Of those 6, 2 were enrolled in ABFT (3.0%) and 4
were enrolled in FE-NST (6.4%), with no significant dif-
ference between groups (c21 ¼ 0.80, p ¼ .37). Similar to
other suicide attempter studies, we also looked at patients
who came to the study after a recent suicide attempt and
hospitalization (n ¼ 51). Of these recent attempters, 2 were
FIGURE 3 Depressive Symptoms by Treatment at Weeks 0,
4, 8, 12, and 16
Note: ABFT ¼ attachment-based family therapy; BDI ¼ Beck Depression Inventory
II; NST ¼ nondirective supportive therapy. Please note color figure are available
online.
FIGURE 2 Suicide Ideation by Treatment Condition at
Weeks 0, 4, 8, 12, and 16
Note: ABFT ¼ attachment-based family therapy; NST ¼ nondirective supportive
therapy; SID-JR ¼ Suicidal Ideation Questionnaire-Jr. Please note color figures
are available online.
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from the ABFT group (6.9%) and 2 were from the FE-NST
group (9.1%), with no significant difference between
groups (c21 ¼ 0.08, p ¼ .77).
DISCUSSION
This is the first RCT comparing ABFT with an active,
rigorously controlled comparison therapy for treating sui-
cide ideation and depressive symptoms in adolescents.
Although adolescents in ABFT and FE-NST showed sub-
stantial decreases in suicide ideation and depressive symp-
toms, there were no differences in symptom decrease
between the 2 treatment conditions. On average, suicide
ideation decreased 24 points across the 2 treatments,
allowing many adolescents to move into a normative range
below 12 on the SIQ (35% for ABFT, 28% for FE-NST),
with an overall clinical response rate of 69% for ABFT and
62% for FE-NST patients. Rates of suicide attempts after
admission to the trial were low even among adolescents who
had made a recent suicide attempt. These findings might
reflect the efficacy of these 2 relatively brief, low-dose
outpatient treatments for adolescents referred for serious
suicidal thoughts and behaviors. Alternatively, because
depression and suicide ideation are time-sensitive symp-
toms, these outcomes could be influenced by regression to
the mean over the 16 weeks of treatment.
Comparisons with other treatment studies are
complicated by heterogeneity in sample demographics,
inclusion criteria, and outcome measures and by treatment
elements and duration. Nevertheless, some comparison on
suicide attempts and attrition is informative. Of those
patients starting treatment soon after a suicide attempt
(n ¼ 51), 6.9% of ABFT participants and 9.1% of FE-
NST participants made an attempt during the treatment
phase. This compares favorably to a meta-analysis that
failed to find significant decreases in suicide attempts
when active interventions were compared with TAU.33,34
In the Treatment Study of Adolescent Suicide Attempters
(TASA),35 consisting of medication plus CBT plus family,
12% of participants made an attempt within 6 months.36
In another study, 25% of participants in a skills training
condition and 12% in an NST condition reattempted
suicide during the treatment phase. For retention, attrition
from ABFT was 18.2% and attrition from FE-NST was
17.5%, comparable to similar studies.11,35 For treatment
dose, ABFT was delivered as a single modality by a
community therapist, generally once a week (mean 14
sessions). This contrasts with many other studies that use a
multicomponent treatment protocol (eg, individual and
group therapy plus medication), multiple contact hours a
week, and delivery by whole teams of expert therapists.
Thus, the structure of ABFT and NST might fit well
within typical outpatient treatment settings. Future com-
parisons across studies would be strengthened if they
shared common measurement tools and agreed on defi-
nitions of remission, response, clinical significance,
adequate dose, and attrition.
In addition to treatment dose and length of treatment,
which were controlled in the 2 conditions, other common
factors could account for the equivalent efficacy of ABFT
and FE-NST. First, all families entered treatment at mo-
ments of high crisis and were met with supportive staff and
therapists who offered immediate access to treatment, a 24-
hour available crisis hotline, weekly check-in phone calls,
home visits as needed, and assistance with social services,
school, or medication consults. These treatment features
and special attention to retention should be considered
essential and best practice for this population. The
responsiveness of the program alone could have accounted
for some of the treatment response and low rates of suicide
attempts in the study.37 Second, the therapist crossover
design and high treatment adherence provided consistent
empathy, support, and treatment fidelity and controlled for
the possible confound of treatment allegiance, all of which
have been associated with treatment outcome.11 Third, the
2 treatments shared many common elements, including
family safety planning, parent involvement, and parent
psychoeducation and support, validation, and empathy in
individual sessions with adolescents and parent(s) alone.20
Fourth, although investigators usually view NST as a con-
trol treatment, it has proved equivalent to CBT in a meta-
analysis of treatment studies for adults with depression after
controlling for treatment allegiance.12
Treatment outcomes also might have resulted from
mechanisms specific to ABFT and FE-NST.38 In ABFT,
the primary aim is to improve trust and communication in
the parent–adolescent dyad. These improvements are hy-
pothesized to lessen family conflict and emotional chaos and
increase an adolescent’s reliance on parents as a safety net.
Addressing these attachment ruptures can lead to more
coherent (ie, secure) attachment schemas and a variety of
mental health benefits (eg, improved self-worth, better
emotion regulation). Possibly ABFT would be fortified by
integrating more specific cognitive and emotional skills
training (eg, parent or adolescent psychoeducation, CBT, or
dialectical behavioral therapy techniques). Thus, building a
more multicomponent ABFT treatment program might be
worthy of investigation.
Alternatively, NST focuses on the therapist establishing
a supportive relationship with the adolescent through
reflective and empathic listening. This clinical process is
similar to mentalization-based therapy, which focuses on
reflective conversations that are alleged to change the
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adolescent’s self-understanding, sense of agency, and self-
regulatory capacities.39 In NST the adolescent’s relation-
ship with the therapist is primary and was evident in higher
ratings of the therapeutic alliance in the NST than in the
ABFT condition.40 These findings suggest that ABFT
might be potentiated by increasing the amount of individual
time devoted to the adolescent and adding individual skill
training or medication elements to the treatment protocol.
Building a more multicomponent treatment program might
be worthy of investigation.
The failure to confirm the superiority of ABFT over
FE-NST is consistent with many RCTs of 2 active treat-
ments that fail to demonstrate the superiority of a specific
treatment.41,42 However, there are several notable limita-
tions to the present findings. First, although nearly 70% of
patients reported clinically significant change, only 40%
obtained remission (nonclinical symptoms) by the end of 16
weeks. Some patients might have needed a longer treat-
ment, additional treatments, or another type of treatment.
Second, the 2 treatments were delivered in a highly regarded
children’s hospital and university, which engenders the kind
of institutional alliance that has often been associated with
better outcomes.43 Testing these treatments in real-world
clinical settings might be needed to evaluate their true
clinical value. ABFT has shown some promise in this
area.9,10 Future examination of long-term outcomes, treat-
ment moderators and mediators, and relapse might help
determine what kind of patients responded best to which
treatment.
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